2010
DOI: 10.5155/eurjchem.1.4.348-351.110 View full text |Buy / Rent full text
|
|

Abstract: KEYWORDSThe introduced study portrays the development and validation of an effortless, speedy and selective first order derivative zero-crossing spectrophotometric method to estimate ezetimibe and simvastatin simultaneously in combined drug products over and above in the presence of ezetimibe alkaline degradation products. Ezetimibe and its alkaline degradates spectra showed zero-crossing point at 249 nm, so the amplitude at 249 nm could be used for calculating the concentration of simvastatin. While simvastat… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
3
0

Publication Types

Select...

Relationship

0
0

Authors

Journals